Cargando…

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem in many countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD. Berberrubine (BRB) is one of the main active metabolites of BBR, which shows significant anti-obesity and antihypoglycemic effects. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sa, Cao, Shijie, Li, Congyu, Zhang, Jichao, Liu, Chang, Qiu, Feng, Kang, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304582/ https://www.ncbi.nlm.nih.gov/pubmed/35873595 http://dx.doi.org/10.3389/fphar.2022.913378

Ejemplares similares

Berberine and Its Main Metabolite Berberrubine Inhibit Platelet Activation Through Suppressing the Class I PI3Kβ/Rasa3/Rap1 Pathway
por: Wang, Can, et al.
Publicado: (2021)

Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity
por: Wang, Kai, et al.
Publicado: (2020)

Berberrubine Phosphate: A Selective Fluorescent Probe for Quadruplex DNA
por: Wickhorst, Peter Jonas, et al.
Publicado: (2021)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
por: Zhang, Xiao-Lei, et al.
Publicado: (2023)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice
por: Yu, Xiu-Ting, et al.
Publicado: (2018)

Structure—yeast α-glucosidase inhibitory activity relationship of 9-O-berberrubine carboxylates
por: Nguyen, Duy Vu, et al.
Publicado: (2023)

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
por: Zhou, Jin, et al.
Publicado: (2021)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2021)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
por: Feng, Xinchi, et al.
Publicado: (2021)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota
por: Wu, Chenyang, et al.
Publicado: (2022)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Berberine in Non-Alcoholic Fatty Liver Disease—A Review
por: Koperska, Anna, et al.
Publicado: (2022)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Pectin from Citrus unshiu Marc. Alleviates Glucose and Lipid Metabolism by Regulating the Gut Microbiota and Metabolites
por: Ren, Yanming, et al.
Publicado: (2023)

Berberine regulates glucose metabolism in largemouth bass by modulating intestinal microbiota
por: Xia, Yun, et al.
Publicado: (2023)

Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
por: Li, Hu, et al.
Publicado: (2021)

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats
por: Dai, Yufan, et al.
Publicado: (2022)

Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ji, Yun, et al.
Publicado: (2019)

Alleviation Effects of Microbial Metabolites from Resveratrol on Non-Alcoholic Fatty Liver Disease
por: Guo, Jingling, et al.
Publicado: (2022)

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
por: Cheng, Hao, et al.
Publicado: (2022)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function
por: Yu, Shenglan, et al.
Publicado: (2022)

The gut microbiota metabolite indole alleviates liver inflammation in mice
por: Beaumont, Martin, et al.
Publicado: (2018)

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
por: Wang, Han, et al.
Publicado: (2022)

Effects of Berberine on the Gastrointestinal Microbiota
por: Zhang, Lichao, et al.
Publicado: (2021)

Alleviation of Alcoholic Fatty Liver by Dendrobium officinale Flower Extracts due to Regulation of Gut Microbiota and Short-Chain Fatty Acids in Mice Exposed to Chronic Alcohol
por: Zhang, Jingchi, et al.
Publicado: (2023)

Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats
por: Shen, Shu-Hua, et al.
Publicado: (2020)

Modulating gut microbiota as an anti-diabetic mechanism of berberine
por: Han, Junling, et al.
Publicado: (2011)

Berberine influences multiple diseases by modifying gut microbiota
por: Yang, Fujie, et al.
Publicado: (2023)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease
por: Li, Sha, et al.
Publicado: (2020)

9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity
por: Chang, Jia-Ming, et al.
Publicado: (2021)

Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
por: Cao, Feiwei, et al.
Publicado: (2023)

Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae
por: Gan, Lin, et al.
Publicado: (2023)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5dicqudjnm28449lo2fbc48mrm